Dova Pharmaceuticals

Dova is a pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for rare diseases where there is a high unmet need, with an initial focus on addressing thrombocytopenia. Dova’s lead drug product was approved by the US FDA in May 2018 and in June 2019 the FDA approved a second indication. In June 2019, Dova also received it's first approval in the EU.Headquartered in Durham, NC, Dova continues to build its teams, resulting in our hiring needs. With a nimble approach and a team of bright minds aglow with passion, we’re dedicated to bringing brilliant medicine to market.